Why the study?
Tricuspid regurgitation is common, progressive, and impairs survival, but surgical rates remain very low and many indicated patients are left untreated.
This expert opinion document summarizes available data, patient selection, imaging considerations, and procedural techniques for percutaneous tricuspid edge-to-edge repair in patients with tricuspid regurgitation.
Answers are grounded in this paper and cite their sources.
Facilitates standardized tricuspid TEER implementation; consolidates expert guidance to inform practice and future trials.
Tricuspid regurgitation (TR) is a common acquired valvular heart disease (VHD). TR has progressive character and is associated with impaired long-term survival in both symptomatic and asymptomatic subjects. Despite this knowledge, the overall number of tricuspid valve surgeries is very low worldwide and many patients with clear indications for intervention are left untreated. The development of less invasive transcatheter techniques may offer new treatment options in this growing population of patients. Out of various percutaneous methods proposed, tricuspid edge-to-edge repair has recently gained considerable attention. The article summarizes available data regarding this new treatment method.
No takes yet. Share an insight, caveat, or question.
Rdzanek et al. (2021) conducted a review in Tricuspid regurgitation. Percutaneous tricuspid edge-to-edge repair was evaluated. Percutaneous tricuspid edge-to-edge repair provides a safe and effective treatment for severe tricuspid regurgitation, with over 80% of patients achieving a significant reduction to moderate or less regurgitation postoperatively.
Synapse has enriched 10 related papers. Consider them for comparative context: